Natera, Inc. (NTRA)
327.72
-4.31
(-1.30%)
USD |
NASDAQ |
Aug 24, 16:00
327.87
+0.15
(+0.05%)
After-Hours: 20:00
Natera Debt to Equity Ratio : 0.1309 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.1309 |
| March 31, 2026 | 0.1353 |
| December 31, 2025 | 0.1252 |
| September 30, 2025 | 0.1587 |
| June 30, 2025 | 0.1574 |
| March 31, 2025 | 0.1578 |
| December 31, 2024 | 0.1565 |
| September 30, 2024 | 0.5415 |
| June 30, 2024 | 0.5231 |
| March 31, 2024 | 0.5538 |
| December 31, 2023 | 0.5775 |
| September 30, 2023 | 0.5638 |
| June 30, 2023 | 0.7452 |
| March 31, 2023 | 0.6848 |
| December 31, 2022 | 0.6323 |
| September 30, 2022 | 1.151 |
| June 30, 2022 | 0.9046 |
| March 31, 2022 | 0.744 |
| December 31, 2021 | 0.608 |
| September 30, 2021 | 0.5078 |
| June 30, 2021 | 1.289 |
| March 31, 2021 | 1.037 |
| December 31, 2020 | 0.5781 |
| Date | Value |
|---|---|
| September 30, 2020 | 0.5183 |
| June 30, 2020 | 0.9097 |
| March 31, 2020 | 0.5934 |
| December 31, 2019 | 0.5591 |
| September 30, 2019 | 1.855 |
| June 30, 2019 | 1.700 |
| March 31, 2019 | 31.97 |
| December 31, 2018 | 3.840 |
| September 30, 2018 | 2.182 |
| June 30, 2018 | -5.597 |
| March 31, 2018 | -31.80 |
| December 31, 2017 | 4.846 |
| September 30, 2017 | 4.049 |
| June 30, 2017 | 0.9625 |
| March 31, 2017 | 0.6651 |
| December 31, 2016 | 0.4602 |
| September 30, 2016 | 0.3492 |
| June 30, 2016 | 0.3011 |
| March 31, 2016 | 0.2324 |
| December 31, 2015 | 0.2278 |
| September 30, 2015 | 0.1032 |
| June 30, 2015 | 0.6486 |
| March 31, 2015 | 0.4618 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Guardant Health, Inc. | -7.614 |
| CareDx, Inc. | 0.0452 |
| Myriad Genetics, Inc. | 0.6927 |
| BioRestorative Therapies, Inc. | 0.0114 |
| Exagen, Inc. | 2.264 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 2.657B |
| Total Liabilities (Quarterly) | 836.00M |
| Shareholders Equity (Quarterly) | 1.821B |
| Current Ratio | 2.999 |
| Net Debt Paydown Yield | -0.02% |